Genevestigator

Industry Bioinformatics
Headquarters Zurich, Switzerland
Website www.genevestigator.com

Genevestigator is an innovative online platform enabling researchers to globally explore public and proprietary expression data for research and clinical applications. It's a web-based application developed for biologists and medical researchers to rapidly find out how genes are expressed in different tissues, stimuli, drug treatments, diseases, or genetic modifications. Results are processed from a large database of manually curated and quality-controlled microarrays and RNAseq samples from a large variety of tissues and conditions. Currently, data is available for human, mouse, rat, pig, drosophila, arabidopsis, barley, rice, wheat, tomato, tobacco, moss and soybean.

Genevestigator was started in January 2004 by scientists from ETH Zurich and is currently developed and commercialized by Nebion AG.

Tool for biologists and medical researchers

Genevestigator is currently serving a community of 44,000 registered users (mostly biologists) from the animal and plant research fields. Its tools have been used in molecular biology, toxicogenomics, and biomarker discovery/validation.

As of May 2014, its original articles have been cited more than 2,500 times by researchers using the tools.

Three tool sets, each containing several tools, are available:

Underlying most of the tools is the concept of "meta-profiles". Meta-profiles are representative vectors of expression for a given type of condition. For example, for a gene of interest, its anatomy meta-profile is the vector of expression values across all anatomy categories that are available in the database for this gene and organism. In simple terms, it shows how strongly a gene is expressed in different anatomy parts. This holds true also for stages of development or perturbations, which are also summarized into representative expression responses.

The concept of meta-profiles has been used in Genevestigator to characterize expression across anatomy, development, stimuli (drug treatments, diseases, stimuli) and mutations.

See also

References

This article is issued from Wikipedia - version of the Sunday, February 15, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.